FBIOX
Price
$23.63
Change
+$0.12 (+0.51%)
Updated
Oct 17 closing price
Net Assets
4.54B
SHSAX
Price
$62.78
Change
+$0.32 (+0.51%)
Updated
Oct 17 closing price
Net Assets
6.26B
Interact to see
Advertisement

FBIOX vs SHSAX

Header iconFBIOX vs SHSAX Comparison
Open Charts FBIOX vs SHSAXBanner chart's image
Fidelity Select Biotechnology
Price$23.63
Change+$0.12 (+0.51%)
VolumeN/A
Net Assets4.54B
BlackRock Health Sciences Opps Inv A
Price$62.78
Change+$0.32 (+0.51%)
VolumeN/A
Net Assets6.26B
FBIOX vs SHSAX Comparison Chart in %
View a ticker or compare two or three
VS
FBIOX vs. SHSAX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBIOX is a Buy and SHSAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SHSAX has more cash in the bank: 6.26B vs. FBIOX (4.54B). FBIOX pays higher dividends than SHSAX: FBIOX (1.02) vs SHSAX (0.22). FBIOX was incepted earlier than SHSAX: FBIOX (40 years) vs SHSAX (26 years). SHSAX (1.09) is less costly to investors than FBIOX (0.63). SHSAX is a more actively managed with annual turnover of: 43.00 vs. FBIOX (38.00). FBIOX has a lower initial minimum investment than SHSAX: FBIOX (0) vs SHSAX (1000). FBIOX annual gain was more profitable for investors over the last year : 9.22 vs. SHSAX (-12.43). FBIOX return over 5 years is better than : -4.73 vs. SHSAX (-14.20).
FBIOXSHSAXFBIOX / SHSAX
Total Expense Ratio0.631.0958%
Annual Report Gross Expense Ratio0.631.0958%
Fund Existence40 years26 years-
Gain YTD24.8670.03277,632%
Front LoadN/A5%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.54B6.26B73%
Annual Yield % from dividends1.020.22460%
Returns for 1 year9.22-12.43-74%
Returns for 3 years51.832.891,793%
Returns for 5 years-4.73-14.2033%
Returns for 10 years9.9323.9841%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CWVCX21.49N/A
N/A
Calvert International Equity C
PAFDX37.08N/A
N/A
T. Rowe Price Equity Income Advisor
MCEIX16.36N/A
N/A
ClearBridge Emerging Markets I
CENTX14.40N/A
N/A
Centerstone Investors I
HFYCX13.23N/A
N/A
Hartford Schroders Intl Multi-Cp Val C